WallStreetZenWallStreetZen

NASDAQ: ITOS
Iteos Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ITOS past revenue growth

How has ITOS's revenue growth performed historically?
Company
-95.29%
Industry
151.46%
Market
17.61%
ITOS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ITOS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ITOS earnings and revenue history

Current Revenue
$12.6M
Current Earnings
-$112.6M
Current Profit Margin
-894.3%

ITOS Return on Equity

Current Company
-18.4%
Current Industry
-63.5%
Current Market
188%
ITOS's Return on Equity (-18.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ITOS announces earnings.

ITOS Return on Assets

Current Company
-16.2%
Current Industry
2.9%
ITOS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ITOS Return on Capital Employed

Current Company
-17.37%
Current Industry
19.5%
ITOS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ITOS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ITOS$12.60M-$108.13M-$112.64M-80.89%N/A
MREO$10.00M-$27.34M-$29.47M-53.16%N/A
MNMD$0.00-$92.57M-$95.73MN/AN/A
ANRO$0.00-$34.28M-$36.31M-100.00%N/A
CBUS$1.82M-$244.57M-$267.63M+50.41%N/A
View Top Biotech Stocks

ITOS earnings dates

Next earnings date
May 8, 2024

Iteos Therapeutics Earnings & Revenue FAQ

What were ITOS's earnings last quarter?

On Invalid Date, Iteos Therapeutics (NASDAQ: ITOS) reported Q4 2023 earnings per share (EPS) of -$0.85, up 246.55% year over year. Total Iteos Therapeutics earnings for the quarter were -$30.55 million. In the same quarter last year, Iteos Therapeutics's earnings per share (EPS) was $0.58.

If you're new to stock investing, here's how to buy Iteos Therapeutics stock.

What was ITOS's earnings growth in the past year?

As of Q2 2024, Iteos Therapeutics's earnings has grown year over year. Iteos Therapeutics's earnings in the past year totalled -$112.64 million.

What is ITOS's earnings date?

Iteos Therapeutics's earnings date is Invalid Date. Add ITOS to your watchlist to be reminded of ITOS's next earnings announcement.

What was ITOS's revenue last quarter?

On Invalid Date, Iteos Therapeutics (NASDAQ: ITOS) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Iteos Therapeutics's revenue was $53.91 million.

What was ITOS's revenue growth in the past year?

As of Q2 2024, Iteos Therapeutics's revenue has grown -95.29% year over year. This is 246.75 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Iteos Therapeutics's revenue in the past year totalled $12.60 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.